PMID: 31959736 Last updated: March 25, 2026
Combination Therapy: The Synergistic Approach Progressive clinicians have discovered that combining multiple peptides creates synergistic effects
Products are not therapeutic goods, are not TGA-approved, and are not for human or animal consumption
The FDA found no clinical studies or publicly available human exposure data for administered MOTS-c, no adequate toxicology, uncertain characterisation and unresolved immunogenicity.[6] The same caution applies to a large range of other non-GLP-1-related peptides that are promoted well beyond the supporting human evidence and in the absence of adequate safety data.[8] Unapproved peptides are not included in the Australian Register of Therapeutic Goods and have not been evaluated by the TGA for safety, quality or effectiveness
In vitro, it has been shown to influence expression of over 4,000 genes at low nanomolar concentrations
Varje batch genomgr omfattande laboratorietester fr att skerstlla renhet, stabilitet och korrekt kopparbindning